This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2010 Jan;6(1):13-4.

doi: 10.1038/nrneph.2009.207.

Cytomegalovirus prophylaxis: how long is enough?

Deepali Kumar, Atul Humar

PMID: 20023684
DOI: 10.1038/nrneph.2009.207

Cytomegalovirus prophylaxis: how long is enough?

Deepali Kumar et al. Nat Rev Nephrol. 2010 Jan.

. 2010 Jan;6(1):13-4.

doi: 10.1038/nrneph.2009.207.

Authors

Deepali Kumar, Atul Humar

PMID: 20023684
DOI: 10.1038/nrneph.2009.207

No abstract available

PubMed Disclaimer

Similar articles

Cytomegalovirus.
[No authors listed] [No authors listed] Am J Transplant. 2004 Nov;4 Suppl 10:51-8. doi: 10.1111/j.1600-6135.2004.00727.x. Am J Transplant. 2004. PMID: 15504213 Review. No abstract available.
Prolonged Low-Dose Prophylaxis With Valganciclovir in Cytomegalovirus-Negative Recipients of Kidney Transplants From Cytomegalovirus-Positive Donors Allows Seroconversion and Prevents Cytomegalovirus Disease.
Halleck F, Khadzhynov D, Schrezenmeier E, Lehner L, Budde K, Staeck O. Halleck F, et al. Transplant Proc. 2017 Dec;49(10):2280-2284. doi: 10.1016/j.transproceed.2017.10.004. Transplant Proc. 2017. PMID: 29198661
Prophylaxis of cytomegalovirus infection in renal transplantation.
Kuypers DR, Vanrenterghem Y. Kuypers DR, et al. Nephrol Dial Transplant. 1998 Dec;13(12):3012-6. doi: 10.1093/ndt/13.12.3012. Nephrol Dial Transplant. 1998. PMID: 9870456 Review. No abstract available.
Preemptive oral ganciclovir therapy versus prophylaxis to prevent symptomatic cytomegalovirus infection after kidney transplantation.
Jung C, Engelmann E, Borner K, Offermann G. Jung C, et al. Transplant Proc. 2001 Nov-Dec;33(7-8):3621-3. doi: 10.1016/s0041-1345(01)02558-1. Transplant Proc. 2001. PMID: 11750538 Clinical Trial. No abstract available.
Gancyclovir prophylaxis in high risk patients.
Campino A. Campino A. Transplant Proc. 2005 Dec;37(10):4311-2. doi: 10.1016/j.transproceed.2005.10.125. Transplant Proc. 2005. PMID: 16387106

See all similar articles

Cited by

The time is now: moving toward virus-specific T cells after allogeneic hematopoietic stem cell transplantation as the standard of care.
Saglio F, Hanley PJ, Bollard CM. Saglio F, et al. Cytotherapy. 2014 Feb;16(2):149-59. doi: 10.1016/j.jcyt.2013.11.010. Cytotherapy. 2014. PMID: 24438896 Free PMC article. Review.
Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation.
Hanley PJ, Shaffer DR, Cruz CR, Ku S, Tzou B, Liu H, Demmler-Harrison G, Heslop HE, Rooney CM, Gottschalk S, Bollard CM. Hanley PJ, et al. Cytotherapy. 2011 Sep;13(8):976-86. doi: 10.3109/14653249.2011.575356. Epub 2011 May 4. Cytotherapy. 2011. PMID: 21539497 Free PMC article.
Cellular immune therapy for viral infections in transplant patients.
Khanna R, Smith C. Khanna R, et al. Indian J Med Res. 2013 Nov;138(5):796-807. Indian J Med Res. 2013. PMID: 24434332 Free PMC article. Review.

References

1. J Am Soc Nephrol. 2009 Nov;20(11):2449-58 - PubMed
1. Am J Transplant. 2009 May;9(5):1214-22 - PubMed
1. J Infect Dis. 2004 May 1;189(9):1615-8 - PubMed
1. Am J Transplant. 2005 May;5(5):1065-70 - PubMed
1. Am J Transplant. 2004 Apr;4(4):611-20 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information